Case number 1:17-cv-01020
Takeda Pharmaceuticals U.S.A., Inc. v. Hetero Labs Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 17, 2018 | 18 | Patent/Trademark Report to Commissioner (2) |
| Jan 17, 2018 | 18 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US 7,981,938; US 8,093,296; US 8,097,655; US 8,415,395; US 8,415,396; US 8,440,721; US 8,440,722. (Attachments: # (1) Order)(nms) |
| Jan 17, 2018 | 18 | Order (2) |
| Jan 16, 2018 | 17 | Order (2) Docket Text: SO ORDERED Granting [16] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 1/16/2018. (nms) |
| Jan 12, 2018 | 16 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal Without Prejudice, by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) Modified on 1/12/2018 (nms). |
| Nov 29, 2017 | 15 | Order (2) Docket Text: SO ORDERED Granting [14] Stipulation and order to Stay Action Pending Regulatory Review of Settlement. Signed by Judge Richard G. Andrews on 11/29/2017. (nms) |
| Nov 29, 2017 | 14 | Stipulation (2) Docket Text: STIPULATION and Proposed Order to Stay Action Pending Regulatory Review of Settlement by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) |
| Nov 10, 2017 | 13 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Drugs Limited for Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc.. (Ormerod, Eve) |
| Nov 10, 2017 | 12 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint,, by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc..(Belgam, Neal) |
| Nov 1, 2017 | 11 | Notice (Other) (1) Docket Text: NOTICE of Firm Name Change by Takeda Pharmaceuticals U.S.A., Inc. (Bourke, Mary) |
| Oct 12, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to November 10, 2017 (*Reset Answer Deadlines: Hetero Labs Limited answer due 11/10/2017; Hetero Labs Limited Unit-V answer due 11/10/2017; Hetero USA Inc. answer due 11/10/2017). Signed by Judge Richard G. Andrews on 10/12/2017. (nms) |
| Oct 11, 2017 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to November 10, 2017 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) |
| Sep 27, 2017 | N/A | SO ORDERED (0) |
| Sep 26, 2017 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to October 20, 2017 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) |
| Aug 3, 2017 | N/A | SO ORDERED (0) |
| Aug 1, 2017 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to September 29, 2017 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) |
| Aug 1, 2017 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Takeda Pharmaceuticals U.S.A., Inc.: For Hetero Labs Limited waiver sent on 7/31/2017, answer due 9/29/2017; Hetero Labs Limited Unit-V waiver sent on 7/31/2017, answer due 9/29/2017. (Bourke, Mary) |
| Aug 1, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. Hetero USA Inc. served on 7/27/2017, answer due 8/17/2017. (Bourke, Mary) |
| Jul 26, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:17-cv-01019-RGA, 1:17-cv-01020-RGA (rjb) |
| Jul 26, 2017 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: added correct related case number 16-cv-987-RGA and removed incorrect case 17-cv-987 Associated Cases: 1:17-cv-01019-UNA, 1:17-cv-01020-UNA(rjb) |
| Jul 25, 2017 | 1 | Exhibit T (7) |
| Jul 25, 2017 | 1 | Exhibit U (4) |
| Jul 25, 2017 | 1 | Civil Cover Sheet (2) |
| Jul 25, 2017 | 1 | Exhibit K (28) |
| Jul 25, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm) |
| Jul 25, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/21/2017. Date of Expiration of Patent: 12/3/2028.Thirty Month Stay Deadline: 12/21/2019. (lmm) |
| Jul 25, 2017 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297. (lmm) |
| Jul 25, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceutical International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc.. (lmm) |
| Jul 25, 2017 | 1 | Exhibit S (26) |
| Jul 25, 2017 | 1 | Exhibit R (27) |
| Jul 25, 2017 | 1 | Exhibit Q (31) |
| Jul 25, 2017 | 1 | Exhibit P (31) |
| Jul 25, 2017 | 1 | Exhibit O (19) |
| Jul 25, 2017 | 1 | Exhibit N (19) |
| Jul 25, 2017 | 1 | Exhibit M (35) |
| Jul 25, 2017 | 1 | Exhibit L (36) |
| Jul 25, 2017 | 1 | Exhibit J (26) |
| Jul 25, 2017 | 1 | Exhibit I (16) |
| Jul 25, 2017 | 1 | Exhibit H (16) |
| Jul 25, 2017 | 1 | Exhibit G (27) |
| Jul 25, 2017 | 1 | Exhibit F (29) |
| Jul 25, 2017 | 1 | Exhibit E (19) |
| Jul 25, 2017 | 1 | Exhibit D (16) |
| Jul 25, 2017 | 1 | Exhibit C (23) |
| Jul 25, 2017 | 1 | Exhibit B (16) |
| Jul 25, 2017 | 1 | Exhibit A (25) |
| Jul 25, 2017 | 1 | Complaint (38) |
| Jul 25, 2017 | 1 | Main Document (38) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2189341.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit L, # (12) Exhibit M, # (13) Exhibit N, # (14) Exhibit O, # (15) Exhibit P, # (16) Exhibit Q, # (17) Exhibit R, # (18) Exhibit S, # (19) Exhibit T, # (20) Exhibit U, # (21) Civil Cover Sheet)(lmm) (Additional attachment(s) added on 7/26/2017: # (22) Exhibit K) (lmm). |
| Jul 25, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hetero USA Inc. on 7/25/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lmm) |
| Jul 25, 2017 | 1 | Complaint* (1) |
